• About us
    • About Lindahl
    • How we work
    • Said about Lindahl
    • Press
    • Find us
    • Privacy
  • Areas
    • Commercial dispute resolution
    • IT/Tech
    • Intellectual property
    • Life Sciences
    • M&A
    • All areas
  • Our people
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Helsingborg
    • Örebro
  • Latest news
    • Cases and transactions
    • News
    • Events
    • Knowledge
    • Portraits
  • Offices
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Örebro
    • Helsingborg

Lindahl has advised ISR Immune System Regulation Holding AB (publ) regarding investment agreement with Singapore Resources Development PTE. Ltd.

  • Home
  • Latest news
  • Cases and transactions
  • 2021
  • Lindahl has advised ISR Immune System Regulation Holding AB (publ) regarding investment agreement with Singapore Resources Development PTE. Ltd.

Lindahl has advised ISR Immune System Regulation Holding AB (publ) when entering into agreement with Singapore Resources Development PTE. Ltd. regarding investment in subsidiary for development of inhalable covid-19 vaccine.

ISR Immune System Regulation Holding AB (publ) is a drug developing company within the area of immunotherapy. The company performs research and develops novel drugs for treatments of viral infections and cancer. In addition, the company develops inhalable covid-19 vaccine.

Singapore Resources Development PTE. Ltd. is a company specialized in developing business relations and investments in countries such as Indonesia, China and India. By gathering investors to specific business projects the company creates a business platform in the countries best suitable for respective project.

ISR is now heading towards a clinical trials phase of its vaccine program and to establish favorable conditions for further collaborations ISR sets up a specific vaccine company.  Singapore Resources Development PTE. Ltd. invests in tranches and will invest, following the fulfillment of certain conditions, a total of EUR 6,850,000 for a total ownership of about 29 per cent in the subsidiary.

Lindahl’s team mainly consisted of Moritz Veller, Monica Lagercrantz, Johan Åberg, Mikael Nagy and Lisa Liljekvist.

Contact

  • Dr. Moritz Veller

    Stockholm

    moritz.veller@lindahl.se +46 728 583 735
  • Monica Lagercrantz

    Stockholm

    monica.lagercrantz@lindahl.se +46 761 269 109
  • Johan Åberg

    Stockholm

    johan.aberg@lindahl.se +46 761 269 105
  • Mikael Nagy

    Stockholm

    mikael.nagy@lindahl.se +46 733 998 024
  • Lisa Liljekvist

    Stockholm

Pages
  • Start
  • About us
  • Areas
  • Our people
  • Latest news
  • Privacy
Our offices
  • Stockholm reception.stockholm@lindahl.se +46 8 527 70 800
  • Göteborg reception.goteborg@lindahl.se +46 31 799 10 00
  • Malmö reception.malmo@lindahl.se +46 40 664 66 50
  • Uppsala reception.uppsala@lindahl.se +46 18 16 18 50
  • Örebro reception.orebro@lindahl.se +46 19 20 89 00
  • Helsingborg reception.helsingborg@lindahl.se +46 42 17 53 00
Social media
  • Connect with us on social networks: Instagram, Linkedin, Youtube, Facebook,

Disclaimer

The material and information on this site is intended for general informational purposes only and does not constitute legal advice on any specific matter. Please note that all images on Lindahl's website, www.lindahl.se, are subject to intellectual property protection and downloading, publication, copying and/or other use of the images requires the written consent of the rights holder. You'll find Advokatfirman Lindahl KB's general terms and conditions here.

Some cookies are essential, others help us improve your experience by providing insights into how the site is used. For more information, please visit our Cookie Policy.

Essential Cookies

These cookies are necessary for the functionality of the site and cannot be disabled.

Analytics Cookies>

We use Analytics cookies to collect information that gives us insight into how our website is being used. We anonymize IP addresses in Google Analytics. By clicking on Decline we won't save theese cookies.

Decline
We use cookies to get insights on how our site is used and give our visitors the best possible experience